Advanced NSCLC

153P - Chemotherapy with immune-checkpoint inhibitors in first-line treatment metastatic NSCLC patients: Systematic review and literature-based meta-analysis

Authors
  • A. Addeo (Geneva, Switzerland)
  • G. Banna (Catania, Italy)
  • G. Metro (Perugia, (PG), Italy)
  • M. Di Maio (Torino, Italy)
Speakers
  • A. Addeo (Geneva, Switzerland)

Next ePosters
53P - Pulmonary tuberculosis: A hurdle to overcome for early lung cancer diagnosis in TB burden countries
141P - Effect of central nervous system (CNS) metastases in a real-world multicenter cohort study of Spanish ALK-positive non-small cell lung cancer (NSCLC) patients (p)
197P - Effect of surgical treatment on the survival in patients with malignant pleural mesothelioma
59P - Comparison of internal target volume delineation using CT datasets of four-dimensional computed tomography in lung cancer radiotherapy
78P - Lung resection for cancer in patients with heart disease: Management and postoperative outcome
199P - Safety meta-analysis of clinical trials delivering TTFields to the upper torso
79P - Tissue microarray analysis on prognostic value of coexpression of RUNX3 and trimethylated histone H3 lysine 27 in surgically resected patients with stage I non-small cell lung cancer
180TiP - An open-label, randomized, phase I/II trial of IO102 and pembrolizumab, or IO102, pembrolizumab and chemotherapy, as first-line treatment for patients with metastatic non-small cell lung cancer
No ePoster preview available
15P - TTF1 status in non-small cell lung cancer adenocarcinoma: A prognostic factor
No ePoster preview available
80P - High blood platelets levels (BPL): A prognostic factor in patients with early or locally advanced non-small cell lung cancer (NSCLC)